1887
No metrics data to plot.
The attempt to load metrics for this article has failed.
The attempt to plot a graph for these metrics has failed.

Selected Topics in Aerobic Bacteriology

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.
Buy this Microbiology Spectrum Article
Price Non-Member $15.00
  • Authors: Geraldine Hall†1, Karen C. Carroll2
  • Editors: Randall T. Hayden3, Donna M. Wolk4, Karen C. Carroll5, Yi-Wei Tang6
  • VIEW AFFILIATIONS HIDE AFFILIATIONS
    Affiliations: 1: † Deceased, Department of Pathology, Cleveland Clinic, and Lerner College of Medicine, Case Western Reserve University School of Medicine, Cleveland, OH 44106; 2: Division of Medical Microbiology, The Johns Hopkins University School of Medicine, Baltimore, MD 21205; 3: St. Jude’s Children’s Research Hospital, Memphis, TN; 4: Geisinger Clinic, Danville, PA; 5: Johns Hopkins University Hospital, Baltimore, MD; 6: Memorial Sloan-Kettering Institute, New York, NY
  • Source: microbiolspec July 2016 vol. 4 no. 4 doi:10.1128/microbiolspec.DMIH2-0027-2016
  • Received 18 March 2016 Accepted 25 April 2016 Published 08 July 2016
  • Karen C. Carroll, Kcarrol7@jhmi.edu
image of Selected Topics in Aerobic Bacteriology
    Preview this microbiology spectrum article:
    Zoom in
    Zoomout

    Selected Topics in Aerobic Bacteriology, Page 1 of 2

    | /docserver/preview/fulltext/microbiolspec/4/4/DMIH2-0027-2016-1.gif /docserver/preview/fulltext/microbiolspec/4/4/DMIH2-0027-2016-2.gif
  • Abstract:

    Aerobic Gram-positive and Gram-negative bacteria can be important pathogens in the immunocompromised host. These bacteria can be found in many environments, as part of the normal microbiota of the human host and animals, in soil and water, on plants, on fomites in the hospital, and on hospital equipment. This review provides information from relevant studies about what are the most common aerobic bacteria associated with patients who have cancer and/or are being treated for it, or who have other diseases which lead to immunodeficiencies, such as HIV, multiple myeloma, aplastic anemia, chronic diseases, and aging. A discussion of the appropriate laboratory tests needed for diagnosis of aerobic infections and information about antibiotics and susceptibility testing are also included.

  • Citation: Hall† G, Carroll K. 2016. Selected Topics in Aerobic Bacteriology. Microbiol Spectrum 4(4):DMIH2-0027-2016. doi:10.1128/microbiolspec.DMIH2-0027-2016.

Key Concept Ranking

Central Nervous System Diseases
0.52636474
Acute Respiratory Distress Syndrome
0.43030953
0.52636474

References

1. Murray PR, Rosenthal KS, Pfaller MA. 2013. Chapter 21. Bacillus, p 209–215. In Medical Microbiology, 7th ed. Elsevier, Philadelphia, PA. [CrossRef]
2. Hernandez-Milian A, Payeras-Cifre A. 2014. What is new in listeriosis? Biomed Res Int 2014:358051. doi:10.1155/2014/358051.
3. Murray PR, Rosenthal KS, Pfaller MA. 2013. Chapter 22. Listeria and Erysipelothrix, pp 216–221. In Medical Microbiology, 7th ed. Elsevier, Philadelphia, PA.
4. Antony SJ. 2000. Lactobacillemia: an emerging cause of infection in both the immunocompromised and the immunocompetent host. J Natl Med Assoc 92:83–86.
5. Murray PR, Rosenthal KS, Pfaller MA. 2013. Chapter 23. Corynebacterium and other Gram-positive rods, p 222–227. In Medical Microbiology, 7th ed. Elsevier, Philadelphia, PA.
6. Murray PR, Rosenthal KS, Pfaller MA. 2013. Chapter 24. Nocardia and related genera, p 228–234. In Medical Microbiology, 7th ed. Elsevier, Philadelphia, PA.
7. Lebeaux D, Morelon E, Suarez F, Lanternier F, Scemla A, Frange P, Mainardi JL, Lecuit M, Lortholary O. 2014. Nocardiosis in transplant recipients. Eur J Clin Microbiol Infect Dis 33:689–702. [CrossRef]
8. Menon V, Gottlieb T, Gallagher M, Cheong EL. 2012. Persistent Rhodococcus equi infection in a renal transplant patient: case report and review of the literature. Transpl Infect Dis 14:E126–E133. [CrossRef]
9. Verma P, Brown JM, Nunez VH, Morey RE, Steigerwalt AG, Pellegrini GJ, Kessler HA. 2006. Native valve endocarditis due to Gordonia polyisoprenivorans: case report and review of literature of bloodstream infections caused by Gordonia species. J Clin Microbiol 44:1905–1908. [CrossRef]
10. Murray PR, Rosenthal KS, Pfaller MA. 2013. Chapter 18. Staphylococcus and related Gram-positive cocci, p 174–187. In Medical Microbiology, 7th ed. Elsevier, Philadelphia, PA.
11. Murray PR, Rosenthal KS, Pfaller MA. 2013. Chapter 19. Streptococcus, p 188–204. In Medical Microbiology, 7th ed. Elsevier, Philadelphia, PA.
12. Shenep JL. 2000. Viridans-group streptococcal infections in immunocompromised hosts. Int J Antimicrob Agents 14:129–135. [CrossRef]
13. Murray PR, Rosenthal KS, Pfaller MA. 2013. Chapter 27. Enterobacteriaceae, p 258–272. In Medical Microbiology, 7th ed. Elsevier, Philadelphia, PA.
14. Murray PR, Rosenthal KS, Pfaller MA. 2013. Chapter 30. Pseudomonas and related bacteria, p 288–295. In Medical Microbiology, 7th ed. Elsevier, Philadelphia, PA.
15. Enoch DA, Birkett CI, Ludlam HA. 2007. Non-fermentative Gram-negative bacteria. Int J Antimicrob Agents 29(Suppl 3):S33–S41. [CrossRef]
16. Fukuta Y, Muder RR, Agha ME, Clarke LG, Wagener MM, Hensler AM, Doi Y. 2013. Risk factors for acquisition of multidrug-resistant Acinetobacter baumannii among cancer patients. Am J Infect Control 41:1249–1252. [CrossRef]
17. Horseman MA, Surani S. 2011. A comprehensive review of Vibrio vulnificus: an important cause of severe sepsis and skin and soft-tissue infection. Int J Infect Dis 15:e157–e166. [CrossRef]
18. Mohle-Boetani JC, Koehler JE, Berger TG, LeBoit PE, Kemper CA, Reingold AL, Plikaytis BD, Wenger JD, Tappero JW. 1996. Bacillary angiomatosis and bacillary peliosis in patients infected with human immunodeficiency virus: clinical characteristics in a case-control study. Clin Infect Dis 22:794–800. [CrossRef]
19. Rostad CA, McElroy AK, Hilinski JA, Thompson MP, Drew CP, Denison AM, Zaki SR, Mahle WT, Rogers J, Abramowsky CR, Shehata B. 2012. Bartonella henselae-mediated disease in solid organ transplant recipients: two pediatric cases and a literature review. Transpl Infect Dis 14:E71–E81. [CrossRef]
20. Psarros G, Riddell J IV, Gandhi T, Kauffman CA, Cinti SK. 2012. Bartonella henselae infections in solid organ transplant recipients: report of 5 cases and review of the literature. Medicine (Baltimore) 91:111–121. [CrossRef]
21. Murray PR, Rosenthal KS, Pfaller MA. 2013. Neisseria and related genera, p 248–257. In Murray PR, Rosenthal KS, Pfaller MA (ed), Medical Microbiology, 7th ed. Elsevier, Philadelphia, PA.
22. Bodey GP. 2009. The changing face of febrile neutropenia—from monotherapy to moulds to mucositis. Fever and neutropenia: the early years. J Antimicrob Chemother 63(Suppl 1):i3–i13. [CrossRef]
23. Wisplinghoff H, Seifert H, Wenzel RP, Edmond MB. 2003. Current trends in the epidemiology of nosocomial bloodstream infections in patients with hematological malignancies and solid neoplasms in hospitals in the United States. Clin Infect Dis 36:1103–1110. [CrossRef]
24. Montassier E, Batard E, Gastinne T, Potel G, de La Cochetière MF. 2013. Recent changes in bacteremia in patients with cancer: a systematic review of epidemiology and antibiotic resistance. Eur J Clin Microbiol Infect Dis 32:841–850. [CrossRef]
25. Mikulska M, Viscoli C, Orasch C, Livermore DM, Averbuch D, Cordonnier C, Akova M. 2013. Fourth European Conference on Infections in Leukemia Group (ECIL-4), a joint venture of EBMT, EORTC, ICHS, ELN and ESGICH/ESCMID. 2014. Aetiology and resistance in bacteraemias among adult and paediatric haematology and cancer patients. J Infect 68:321–331. [CrossRef]
26. Trecarichi EM, Tumbarello M. 2014. Antimicrobial-resistant Gram-negative bacteria in febrile neutropenic patients with cancer: current epidemiology and clinical impact. Curr Opin Infect Dis 27:200–210. [CrossRef]
27. Safdar A, Rodriguez GH, Balakrishnan M, Tarrand JJ, Rolston KV. 2006. Changing trends in etiology of bacteremia in patients with cancer. Eur J Clin Microbiol Infect Dis 25:522–526. [CrossRef]
28. Mahajan SN, Shah JN, Hachem R, Tverdek F, Adachi JA, Mulanovich V, Rolston KV, Raad II, Chemaly RF. 2012. Characteristics and outcomes of methicillin-resistant Staphylococcus aureus bloodstream infections in patients with cancer treated with vancomycin: 9-year experience at a comprehensive cancer center. Oncologist 17:1329–1336. [CrossRef]
29. Jacobson KL, Miceli MH, Tarrand JJ, Kontoyiannis DP. 2008. Legionella pneumonia in cancer patients. Medicine (Baltimore) 87:152–159. [CrossRef]
30. Lanternier F, Tubach F, Ravaud P, Salmon D, Dellamonica P, Bretagne S, Couret M, Bouvard B, Debandt M, Gueit I, Gendre JP, Leone J, Nicolas N, Che D, Mariette X, Lortholary O, Research Axed on Tolerance of Biotherapies Group. 2013. Incidence and risk factors of Legionella pneumophila pneumonia during anti-tumor necrosis factor therapy: a prospective French study. Chest 144:990–998. [CrossRef]
31. Tubach F, Ravaud P, Salmon-Céron D, Petitpain N, Brocq O, Grados F, Guillaume JC, Leport J, Roudaut A, Solau-Gervais E, Lemann M, Mariette X, Lortholary O, Recherce Axée sur la Tolérance des Biothérapies Group. 2006. Emergence of Legionella pneumophila pneumonia in patients receiving tumor necrosis factor-alpha antagonists. Clin Infect Dis 43:e95–e100. [CrossRef]
32. Marín M, Gudiol C, Garcia-Vidal C, Ardanuy C, Carratalà J. 2014. Bloodstream infections in patients with solid tumors: epidemiology, antibiotic therapy, and outcomes in 528 episodes in a single cancer center. Medicine (Baltimore) 93:143–149. [CrossRef]
33. Chen CY, Tsay W, Tang JL, Tien HF, Chen YC, Chang SC, Hsueh PR. 2010. Epidemiology of bloodstream infections in patients with haematological malignancies with and without neutropenia. Epidemiol Infect 138:1044–1051. [CrossRef]
34. Samonis G, Vardakas KZ, Kofteridis DP, Dimopoulou D, Andrianaki AM, Chatzinikolaou I, Katsanevaki E, Maraki S, Falagas ME. 2014. Characteristics, risk factors and outcomes of adult cancer patients with extensively drug-resistant Pseudomonas aeruginosa infections. Infection 42:721–728. [CrossRef]
35. Srinivasan A, Seifried S, Zhu L, Srivastava DK, Flynn PM, Bankowski MJ, Shenep JL, Hayden RT. 2010. Staphylococcus aureus bacteremia in pediatric patients with cancer. Pediatr Infect Dis J 29:172–174. [CrossRef]
36. McNeil JC. 2014. Staphylococcus aureus – antimicrobial resistance and the immunocompromised child. Infect Drug Resist 7:117–127. [CrossRef]
37. Al-Mulla NA, Taj-Aldeen SJ, El Shafie S, Janahi M, Al-Nasser AA, Chandra P. 2014. Bacterial bloodstream infections and antimicrobial susceptibility pattern in pediatric hematology/oncology patients after anticancer chemotherapy. Infect Drug Resist 7:289–299. [CrossRef]
38. Marr KA. 2012. Delayed opportunistic infections in hematopoietic stem cell transplantation patients: a surmountable challenge. Hematology (Am Soc Hematol Educ Program) 2012:265–270.
39. Youssef S, Rodriguez G, Rolston KV, Champlin RE, Raad II, Safdar A. 2007. Streptococcus pneumoniae infections in 47 hematopoietic stem cell transplantation recipients: clinical characteristics of infections and vaccine-breakthrough infections, 1989-2005. Medicine (Baltimore) 86:69–77. [CrossRef]
40. Kumar D, Humar A, Plevneshi A, Siegal D, Franke N, Green K, McGeer A, Toronto Invasive Bacterial Diseases Network. 2008. Invasive pneumococcal disease in adult hematopoietic stem cell transplant recipients: a decade of prospective population-based surveillance. Bone Marrow Transplant 41:743–747. [CrossRef]
41. Oliveira AL, de Souza M, Carvalho-Dias VM, Ruiz MA, Silla L, Tanaka PY, Simões BP, Trabasso P, Seber A, Lotfi CJ, Zanichelli MA, Araujo VR, Godoy C, Maiolino A, Urakawa P, Cunha CA, de Souza CA, Pasquini R, Nucci M. 2007. Epidemiology of bacteremia and factors associated with multi-drug-resistant gram-negative bacteremia in hematopoietic stem cell transplant recipients. Bone Marrow Transplant 39:775–781. [CrossRef]
42. Fuji S, Kapp M, Einsele H. 2014. Possible implication of bacterial infection in acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Front Oncol 4:89. [CrossRef]
43. Satlin MJ, Jenkins SG, Walsh TJ. 2014. The global challenge of carbapenem-resistant Enterobacteriaceae in transplant recipients and patients with hematologic malignancies. Clin Infect Dis 58:1274–1283. [CrossRef]
44. Pruitt AA, Graus F, Rosenfeld MR. 2013. Neurological complications of transplantation: part I: hematopoietic cell transplantation. Neurohospitalist 3:24–38. [CrossRef]
45. Robin F, Paillard C, Marchandin H, Demeocq F, Bonnet R, Hennequin C. 2010. Lactobacillus rhamnosus meningitis following recurrent episodes of bacteremia in a child undergoing allogeneic hematopoietic stem cell transplantation. J Clin Microbiol 48:4317–4319. [CrossRef]
46. Ramanan P, Deziel PJ, Wengenack NL. 2013. Gordonia bacteremia. J Clin Microbiol 51:3443–3447. [CrossRef]
47. Ishihara Y, Kanda J, Tanaka K, Nakano H, Ugai T, Wada H, Yamasaki R, Kawamura K, Sakamoto K, Ashizawa M, Sato M, Terasako-Saito K, Kimura S, Kikuchi M, Nakasone H, Yamazaki R, Kako S, Nishida J, Watanabe K, Kanda Y. 2014. Severe oral infection due to Lactobacillus rhamnosus during induction chemotherapy for acute myeloid leukemia. Int J Hematol 100:607–610. [CrossRef]
48. Lanini S, Molloy AC, Prentice AG, Ippolito G, Kibbler CC. 2013. Infections in patients taking Rituximab for hematologic malignancies: two-year cohort study. BMC Infect Dis 13:317. [CrossRef]
49. Dorschner P, McElroy LM, Ison MG. 2014. Nosocomial infections within the first month of solid organ transplantation. Transpl Infect Dis 16:171–187. [CrossRef]
50. Dizdar OS, Ersoy A, Akalin H. 2014. Pneumonia after kidney transplant: incidence, risk factors, and mortality. Exp Clin Transplant 12:205–211.
51. Hollenbeak CS, Alfrey EJ, Sheridan K, Burger TL, Dillon PW. 2003. Surgical site infections following pediatric liver transplantation: risks and costs. Transpl Infect Dis 5:72–78. [CrossRef]
52. Kawecki D, Chmura A, Pacholczyk M, Lagiewska B, Adadynski L, Wasiak D, Malkowski P, Rokosz A, Sawicka-Grzelak A, Szymanowska A, Swoboda-Kopec E, Wroblewska M, Rowinski W, Durlik M, Luczak M. 2007. Etiological agents of bacteremia in the early period after liver transplantation. Transplant Proc 39:2816–2821. [CrossRef]
53. John S, Neary J, Lee CH. 2012. Invasive Bacillus cereus infection in a renal transplant patient: a case report and review. Can J Infect Dis Med Microbiol 23:e109–e110. [CrossRef]
54. Coste JF, Vuiblet V, Moustapha B, Bouin A, Lavaud S, Toupance O, de Rougemont A, Benejat L, Megraud F, Wolak-Thierry A, Villena I, Chemla C, Le Magrex E, de Champs C, Andreoletti L, Rieu P, Leveque N. 2013. Microbiological diagnosis of severe diarrhea in kidney transplant recipients by use of multiplex PCR assays. J Clin Microbiol 51:1841–1849. [CrossRef]
55. Danziger-Isakov L. 2014. Gastrointestinal infections after transplantation. Curr Opin Gastroenterol 30:40–46. [CrossRef]
56. van Delden C. 2014. Bacterial biliary tract infections in liver transplant recipients. Curr Opin Organ Transplant 19:223–228. [CrossRef]
57. Said A, Safdar N, Lucey MR, Knechtle SJ, D’Alessandro A, Musat A, Pirsch J, Kalayoglu M, Maki DG. 2004. Infected bilomas in liver transplant recipients, incidence, risk factors and implications for prevention. Am J Transplant 4:574–582. [CrossRef]
58. Witt CA, Meyers BF, Hachem RR. 2012. Pulmonary infections following lung transplantation. Thorac Surg Clin 22:403–412. [CrossRef]
59. Fish DN, Danziger LH. 1993. Neglected pathogens: bacterial infections in persons with human immunodeficiency virus infection. A review of the literature (first of two parts). Pharmacotherapy 13:415–439.
60. Granger RK, Powderly WG. 2007. Acquired immunodeficiency syndrome, p 679–690. In Engelberg NC, DiRita V, Dermody TS (ed), Schaechter’s Mechanisms of Microbial Disease. Lippincott Williams & Wilkins, Baltimore, MD.
61. Preziosi MJ, Kandel SM, Guiney DG, Browne SH. 2012. Microbiological analysis of nontyphoidal Salmonella strains causing distinct syndromes of bacteremia or enteritis in HIV/AIDS patients in San Diego, California. J Clin Microbiol 50:3598–3603. [CrossRef]
62. Gordon RJ, Chez N, Jia H, Zeller B, Sobieszczyk M, Brennan C, Hisert KB, Lee MH, Vavagiakis P, Lowy FD. 2010. The NOSE study (nasal ointment for Staphylococcus aureus eradication): a randomized controlled trial of monthly mupirocin in HIV-infected individuals. J Acquir Immune Defic Syndr 55:466–472. [CrossRef]
63. Senthilkumar A, Kumar S, Sheagren JN. 2001. Increased incidence of Staphylococcus aureus bacteremia in hospitalized patients with acquired immunodeficiency syndrome. Clin Infect Dis 33:1412–1416. [CrossRef]
64. McNeil JC, Hulten KG, Kaplan SL, Schwarzwald HL, Mason EO. 2012. Staphylococcus aureus infections in HIV-positive children and adolescents. Pediatr Infect Dis J 31:284–286. [CrossRef]
65. Siberry GK, Frederick T, Emmanuel P, Paul ME, Bohannon B, Wheeling T, Barton T, Rathore MH, Dominguez KL. 2012. Methicillin-resistant Staphylococcus aureus infections in human immunodeficiency virus-infected children and adolescents. Aids Res Treat 2012:627974. [CrossRef]
66. Cotton MF, Wasserman E, Smit J, Whitelaw A, Zar HJ. 2008. High incidence of antimicrobial resistant organisms including extended spectrum beta-lactamase producing Enterobacteriaceae and methicillin-resistant Staphylococcus aureus in nasopharyngeal and blood isolates of HIV-infected children from Cape Town, South Africa. BMC Infect Dis 8:40. [CrossRef]
67. Groome MJ, Albrich WC, Wadula J, Khoosal M, Madhi SA. 2012. Community-onset Staphylococcus aureus bacteraemia in hospitalized African children and high prevalence of multidrug resistance. Paediatr Int Child Health 32:140–6. [CrossRef]
68. Marciano BE, Spalding C, Fitzgerald A. 2014. Common severe infections in chronic granulomatous disease. Clin Infect Dis 60:1176–1183. [CrossRef]
69. Overton ET, Powderly WG. 2007. Infections in the immunocompromised host, p 673–678. In Engelberg NC, DiRita V, Dermody TS (ed), Schaechter’s Mechanisms of Microbial Disease, 4th ed. Lippincott, Williams & Wilkins, Baltimore, MD.
70. van den Bruele T, Mourad-Baars PE, Claas EC, van der Plas RN, Kuijper EJ, Bredius RG. 2010. Campylobacter jejuni bacteremia and Helicobacter pylori in a patient with X-linked agammaglobulinemia. Eur J Clin Microbiol Infect Dis 29:1315–1319. [CrossRef]
71. Valdez JM, Scheinberg P, Young NS, Walsh TJ. 2009. Infections in patients with aplastic anemia. Semin Hematol 46:269–276. [CrossRef]
72. Valdez JM, Scheinberg P, Nunez O, Wu CO, Young NS, Walsh TJ. 2011. Decreased infection-related mortality and improved survival in severe aplastic anemia in the past two decades. Clin Infect Dis 52:726–735. [CrossRef]
73. Nucci M, Anaissie E. 2009. Infections in patients with multiple myeloma in the era of high-dose therapy and novel agents. Clin Infect Dis 49:1211–1225. [CrossRef]
74. Offidani M, Corvatta L, Polloni C, Gentili S, Brioni A, Visani G, Galieni P, Brunori M, Alesiani F, Catarini M, Centurioni R, Samori A, Blasi N, Ferranti M, Fraticelli P, Mele A, Rizzi R, Larocca F, Leoni P. 2011. Infectious complications in patients with multiple myeloma treated with new drug combinations containing thalidomide. Leuk Lymphoma 52:776–785. [CrossRef]
75. Savage DG, Lindenbaum J, Garrett TJ. 1982. Biphasic pattern of bacterial infection in multiple myeloma. Ann Intern Med 96:47–50. [CrossRef]
76. Blimark C, Holmberg E, Mellqvist UH, Landgren O, Björkholm M, Hultcrantz M, Kjellander C, Turesson I, Kristinsson SY. 2015. Multiple myeloma and infections: a population-based study on 9253 multiple myeloma patients. Haematologica 100:107–113. [CrossRef]
77. Bellmann-Weiler R, Weiss G. 2009. Pitfalls in the diagnosis and therapy of infections in elderly patients—a mini-review. Gerontology 55:241–249. [CrossRef]
78. Krone CL, van de Groep K, Trzcinski K, Sanders EA, Bogaert D. 2014. Immunosenescence and pneumococcal disease: an imbalance in host-pathogen interactions. Lancet Respir Med 2:141–153. [CrossRef]
79. Girard TD, Ely EW. 2007. Bacteremia and sepsis in older adults. Clin Geriatr Med 23:633–647, viii. [CrossRef]
80. Martin GS, Mannino DM, Moss M. 2006. The effect of age on the development and outcome of adult sepsis. Crit Care Med 34:15–21. [CrossRef]
81. Diekema DJ, Pfaller MA, Jones RN, SENTRY Participants Group. 2002. Age-related trends in pathogen frequency and antimicrobial susceptibility of bloodstream isolates in North America: SENTRY Antimicrobial Surveillance Program, 1997-2000. Int J Antimicrob Agents 20:412–418. [CrossRef]
82. Lewthwaite P, Parsons HK, Bates CJ, McKendrick MW, Dockrell DH. 2002. Group G streptococcal bacteraemia: an opportunistic infection associated with immune senescence. Scand J Infect Dis 34:83–87. [CrossRef]
83. Gavazzi G, Krause KH. 2002. Ageing and infection. Lancet Infect Dis 2:659–666. [CrossRef]
84. Lobo LJ, Noone PG. 2014. Respiratory infections in patients with cystic fibrosis undergoing lung transplantation. Lancet Respir Med 2:73–82. [CrossRef]
85. Abreu C, Magro F, Vilas-Boas F, Lopes S, Macedo G, Sarmento A. 2013. Listeria infection in patients on anti-TNF treatment: report of two cases and review of the literature. J Crohn’s Colitis 7:175–182. [CrossRef]
86. Chavada R, Keighley C, Quadri S, Asghari R, Hofmeyr A, Foo H. 2014. Uncommon manifestations of Listeria monocytogenes infection. BMC Infect Dis 14:641. [CrossRef]
87. Vahabnezhad E, Mochon AB, Wozniak LJ, Ziring DA. 2013. Lactobacillus bacteremia associated with probiotic use in a pediatric patient with ulcerative colitis. J Clin Gastroenterol 47:437–439. [CrossRef]
88. Kroesen S, Widmer AF, Tyndall A, Hasler P. 2003. Serious bacterial infections in patients with rheumatoid arthritis under anti-TNF-alpha therapy. Rheumatology (Oxford) 42:617–621. [CrossRef]
89. Curtis JR, Yang S, Patkar NM, Chen L, Singh JA, Cannon GW, Mikuls TR, Delzell E, Saag KG, Safford MM, DuVall S, Alexander K, Napalkov P, Winthrop KL, Burton MJ, Kamauu A, Baddley JW. 2014. Risk of hospitalized bacterial infections associated with biologic treatment among US veterans with rheumatoid arthritis. Arthritis Care Res (Hoboken) 66:990–997. [CrossRef]
90. Jalan R, Fernandez J, Wiest R, Schnabl B, Moreau R, Angeli P, Stadlbauer V, Gustot T, Bernardi M, Canton R, Albillos A, Lammert F, Wilmer A, Mookerjee R, Vila J, Garcia-Martinez R, Wendon J, Such J, Cordoba J, Sanyal A, Garcia-Tsao G, Arroyo V, Burroughs A, Ginès P. 2014. Bacterial infections in cirrhosis: a position statement based on the EASL Special Conference 2013. J Hepatol 60:1310–1324. [CrossRef]
91. Hutchens A, Gupte A, McAuliffe PF, Schain D, Soldevila-Pico C, Knapik JA, Fujita S, Mozingo DW, Richards WT. 2010. Bacillus cereus necrotizing fasciitis in a patient with end-stage liver disease. Surg Infect (Larchmt) 11:469–474. [CrossRef]
92. Richter SS, Sercia L, Branda JA, Burnham CA, Bythrow M, Ferraro MJ, Garner OB, Ginocchio CC, Jennemann R, Lewinski MA, Manji R, Mochon AB, Rychert JA, Westblade LF, Procop GW. 2013. Identification of Enterobacteriaceae by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry using the VITEK MS system. Eur J Clin Microbiol Infect Dis 32:1571–1578. [CrossRef]
93. Schulthess B, Brodner K, Bloemberg GV, Zbinden R, Böttger EC, Hombach M. 2013. Identification of Gram-positive cocci by use of matrix-assisted laser desorption ionization-time of flight mass spectrometry: comparison of different preparation methods and implementation of a practical algorithm for routine diagnostics. J Clin Microbiol 51:1834–1840. [CrossRef]
94. Fang H, Ohlsson AK, Ullberg M, Ozenci V. 2012. Evaluation of species-specific PCR, Bruker MS, VITEK MS and the VITEK 2 system for the identification of clinical Enterococcus isolates. Eur J Clin Microbiol Infect Dis 31:3073–3077. [CrossRef]
95. Farfour E, Leto J, Barritault M, Barberis C, Meyer J, Dauphin B, Le Guern AS, Leflèche A, Badell E, Guiso N, Leclercq A, Le Monnier A, Lecuit M, Rodriguez-Nava V, Bergeron E, Raymond J, Vimont S, Bille E, Carbonnelle E, Guet-Revillet H, Lécuyer H, Beretti JL, Vay C, Berche P, Ferroni A, Nassif X, Join-Lambert O. 2012. Evaluation of the Andromas matrix-assisted laser desorption ionization-time of flight mass spectrometry system for identification of aerobically growing Gram-positive bacilli. J Clin Microbiol 50:2702–2707. [CrossRef]
96. Couturier MR, Graf EH, Griffin AT. 2014. Urine antigen tests for the diagnosis of respiratory infections: legionellosis, histoplasmosis, pneumococcal pneumonia. Clin Lab Med 34:219–236. [CrossRef]
97. Benitez AJ, Thurman KA, Diaz MH, Conklin L, Kendig NE, Winchell JM. 2012. Comparison of real-time PCR and a microimmunofluorescence serological assay for detection of Chlamydophila pneumoniae infection in an outbreak investigation. J Clin Microbiol 50:151–153. [CrossRef]
98. Mercante JW, Winchell JM. 2015. Current and emerging Legionella diagnostics for laboratory and outbreak investigations. Clin Microbiol Rev 28:95–133. [CrossRef]
99. She RC, Thurber A, Hymas WC, Stevenson J, Langer J, Litwin CM, Petti CA. 2010. Limited utility of culture for Mycoplasma pneumoniae and Chlamydophila pneumoniae for diagnosis of respiratory tract infections. J Clin Microbiol 48:3380–3382. [CrossRef]
100. Andersson ME, Olofsson S, Lindh M. 2014. Comparison of the FilmArray assay and in-house real-time PCR for detection of respiratory infection. Scand J Infect Dis 46:897–901. [CrossRef]
101. Ratliff AE, Duffy LB, Waites KB. 2014. Comparison of the illumigene Mycoplasma DNA amplification assay and culture for detection of Mycoplasma pneumoniae. J Clin Microbiol 52:1060–1063. [CrossRef]
102. Clinical and Laboratory Standards Institute. 2015. Performance Standards for Antimicrobial Disk Susceptibility Tests. Approved standard, 12th ed. CLSI document M02-A12. Clinical and Laboratory Standards Institute, Wayne, PA.
103. Clinical and Laboratory Standards Institute. 2015. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically. Approved standard, 10th ed. CLSI document M07-A10. Clinical and Laboratory Standards Institute, Wayne, PA.
104. Clinical and Laboratory Standards Institute. 2015. Performance Standards for Antimicrobial Susceptibility Testing; 25th Informational Supplement. CLS document M100-S25. Clinical and Laboratory Standards Institute, Wayne, PA.
105. Johansson A, Ekelöf J, Giske CG, Sundqvist M. 2014. The detection and verification of carbapenemases using ertapenem and matrix assisted laser desorption ionization-time of flight. BMC Microbiol 14:89. [CrossRef]
106. Buchan BW, Allen S, Burnham CA, McElvania TeKippe E, Davis T, Levi M, Mayne D, Pancholi P, Relich RF, Thomson R, Ledeboer NA. 2015. Comparison of the Next Generation Xpert MRSA/SA BC and GeneOhm StaphSR assays to routine culture for the identification of Staphylococcus aureus and MRSA in positive blood culture broths. J Clin Microbiol 53:804–809. [CrossRef]
107. Riedel SR, Carroll KC. 2016. Early identification and treatment of pathogens in sepsis-molecular diagnostics and antibiotic choice. Clin Chest Med 37:191–207. [CrossRef]
108. Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, Harbarth S, Hindler JF, Kahlmeter G, Olsson-Liljequist B, Paterson DL, Rice LB, Stelling J, Struelens MJ, Vatopoulos A, Weber JT, Monnet DL. 2012. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 18:268–281. [CrossRef]
109. Ahlstrand E, Svensson K, Persson L, Tidefelt U, Söderquist B. 2011. Glycopeptide resistance in coagulase-negative staphylococci isolated in blood cultures from patients with hematological malignancies during three decades. Eur J Clin Microbiol Infect Dis 30:1349–1354. [CrossRef]
110. Clinical and Laboratory Standards Institute. 2010. Methods for Antimicrobial Dilution and Disk Susceptibility Testing of Infrequently Isolated or Fastidious Bacteria. Approved guideline, 2nd ed. CLSI document M45-A2. Clinical and Laboratory Standards Institute, Wayne PA.
111. Clinical and Laboratory Standards Institute. 2011. Susceptibility Testing of Mycobacteria, Nocardiae, and Other Aerobic Actinomycetes. Approved standard, 2nd ed. CLSI document M24-A2. Clinical and Laboratory Standards Institute, Wayne, PA.
112. Gudiol C, Tubau F, Calatayud L, Garcia-Vidal C, Cisnal M, Sánchez-Ortega I, Duarte R, Calvo M, Carratalà J. 2011. Bacteraemia due to multidrug-resistant Gram-negative bacilli in cancer patients: risk factors, antibiotic therapy and outcomes. J Antimicrob Chemother 66:657–663. [CrossRef]
113. Trecarichi EM, Tumbarello M, Spanu T, Caira M, Fianchi L, Chiusolo P, Fadda G, Leone G, Cauda R, Pagano L. 2009. Incidence and impact of extended-spectrum-β-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by E. coli in patients with hematological malignancies. J Infect 58:299–307. [CrossRef]
114. Liscio JL, Mahoney MV, Hirsch EB. 2015. Ceftolozane/tazobactam and ceftazidime/avibactam: two novel β-lactam/β-lactamase inhibitor combination agents for the treatment of resistant Gram-negative bacterial infections. Int J Antimicrob Agents 46:266–271. [CrossRef]
115. Tomic V, Dowzicky MJ. 2014. Regional and global antimicrobial susceptibility among isolates of Streptococcus pneumoniae and Haemophilus influenzae collected as part of the Tigecycline Evaluation and Surveillance Trial (T.E.S.T.) from 2009 to 2012 and comparison with previous years of T.E.S.T. (2004-2008). Ann Clin Microbiol Antimicrob 13:52. [CrossRef]
microbiolspec.DMIH2-0027-2016.citations
cm/4/4
content/journal/microbiolspec/10.1128/microbiolspec.DMIH2-0027-2016
Loading

Citations loading...

Loading

Article metrics loading...

/content/journal/microbiolspec/10.1128/microbiolspec.DMIH2-0027-2016
2016-07-08
2017-06-29

Abstract:

Aerobic Gram-positive and Gram-negative bacteria can be important pathogens in the immunocompromised host. These bacteria can be found in many environments, as part of the normal microbiota of the human host and animals, in soil and water, on plants, on fomites in the hospital, and on hospital equipment. This review provides information from relevant studies about what are the most common aerobic bacteria associated with patients who have cancer and/or are being treated for it, or who have other diseases which lead to immunodeficiencies, such as HIV, multiple myeloma, aplastic anemia, chronic diseases, and aging. A discussion of the appropriate laboratory tests needed for diagnosis of aerobic infections and information about antibiotics and susceptibility testing are also included.

Highlighted Text: Show | Hide
Loading full text...

Full text loading...

Tables

Generic image for table
TABLE 1

Common aerobic Gram-positive bacilli

Source: microbiolspec July 2016 vol. 4 no. 4 doi:10.1128/microbiolspec.DMIH2-0027-2016
Generic image for table
TABLE 2

Common aerobic Gram-positive cocci

Source: microbiolspec July 2016 vol. 4 no. 4 doi:10.1128/microbiolspec.DMIH2-0027-2016
Generic image for table
TABLE 3

Common aerobic Gram-negative bacilli

Source: microbiolspec July 2016 vol. 4 no. 4 doi:10.1128/microbiolspec.DMIH2-0027-2016
Generic image for table
TABLE 4

Common microbes and infections associated with certain impaired functions in the immune system

Source: microbiolspec July 2016 vol. 4 no. 4 doi:10.1128/microbiolspec.DMIH2-0027-2016

Supplemental Material

No supplementary material available for this content.

This is a required field
Please enter a valid email address
Please check the format of the address you have entered.
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error